Literature DB >> 10356992

Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity.

F Sams-Dodd1.   

Abstract

Phencyclidine (PCP) is a hallucinogenic drug that can mimic several aspects of the schizophrenic symptomatology in healthy volunteers. In a series of studies PCP was administered to rats to determine whether it was possible to develop an animal model of the positive and negative symptoms of schizophrenia. The rats were tested in the social interaction test and it was found that PCP dose-dependently induces stereotyped behaviour and social withdrawal, which may correspond to certain aspects of the positive and negative symptoms, respectively. The effects of PCP could be reduced selectively by antipsychotic drug treatment, whereas drugs lacking antipsychotic effects did not alleviate the PCP-induced behaviours. Together these findings indicate that PCP effects in the rat social interaction test may be a model of the positive and negative symptoms of schizophrenia with face and predictive validity and that it may be useful for the evaluation of novel antipsychotic compounds.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356992     DOI: 10.1515/revneuro.1999.10.1.59

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  29 in total

1.  Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems.

Authors:  Neil Dawson; Brian J Morris; Judith A Pratt
Journal:  Schizophr Bull       Date:  2011-11-22       Impact factor: 9.306

2.  Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Authors:  Céline Risterucci; Karine Jeanneau; Stephanie Schöppenthau; Thomas Bielser; Basil Künnecke; Markus von Kienlin; Jean-Luc Moreau
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

3.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

4.  Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.

Authors:  Emma S Lydall; Gary Gilmour; Dominic M Dwyer
Journal:  Psychopharmacology (Berl)       Date:  2010-02-10       Impact factor: 4.530

Review 5.  Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Authors:  Nikhil Neelkantan; Alina Mikhaylova; Adam Michael Stewart; Raymond Arnold; Visar Gjeloshi; Divya Kondaveeti; Manoj K Poudel; Allan V Kalueff
Journal:  ACS Chem Neurosci       Date:  2013-08-06       Impact factor: 4.418

6.  The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.

Authors:  Hannah F Iaccarino; Raymond F Suckow; Shan Xie; David J Bucci
Journal:  Schizophr Res       Date:  2013-09-30       Impact factor: 4.939

7.  A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats.

Authors:  J David Jentsch; Luigi A Anzivino
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

8.  Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.

Authors:  Christina A Wilson; Alvin V Terry
Journal:  Pharmacol Biochem Behav       Date:  2012-12-31       Impact factor: 3.533

9.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Authors:  Alice Egerton; Lee Reid; Sandie McGregor; Susan M Cochran; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2008-04-23       Impact factor: 4.530

10.  Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.

Authors:  David A Baker; Aric Madayag; Lars V Kristiansen; James H Meador-Woodruff; Vahram Haroutunian; Ilangovan Raju
Journal:  Neuropsychopharmacology       Date:  2007-08-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.